Literature DB >> 12466047

Potential role of tetrandrine in cancer therapy.

Yu-Jen Chen1.   

Abstract

Tetrandrine, a bisbenylisoquinoline alkaloid isolated from the dried root of Stephenia tetrandra S Moore, exhibits very broad pharmacological actions, including anti-tumor activity. The beneficial effects of tetrandrine on tumor cell cytotoxicity and radiosensitization, multidrug resistance, normal tissue radioprotection, and angiogenesis are most promising and deserve great attention. Tetrandrine has potential either as a tumoricidal agent or as an adjunct to chemotherapy and radiotherapy. To evaluate the potential clinical efficacy of tetrandrine for cancer therapy, more mechanism-based pharmacological, pharmacokinetic, and pharmacodynamic studies are required.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12466047

Source DB:  PubMed          Journal:  Acta Pharmacol Sin        ISSN: 1671-4083            Impact factor:   6.150


  17 in total

1.  Effect of five novel 5-substituted tetrandrine derivatives on P-glycoprotein-mediated inhibition and transport in Caco-2 cells.

Authors:  Zhonglian Cao; Dan Li; Li Liu; Ping Yang
Journal:  Oncol Lett       Date:  2018-09-24       Impact factor: 2.967

2.  c-Jun NH2-terminal kinase-induced proteasomal degradation of c-FLIPL/S and Bcl2 sensitize prostate cancer cells to Fas- and mitochondria-mediated apoptosis by tetrandrine.

Authors:  Pankaj Chaudhary; Jamboor K Vishwanatha
Journal:  Biochem Pharmacol       Date:  2014-08-30       Impact factor: 5.858

3.  Tetrandrine enhances radiosensitivity through the CDC25C/CDK1/cyclin B1 pathway in nasopharyngeal carcinoma cells.

Authors:  Jun Wang; Lihong Chang; Xiaoping Lai; Xia Li; Zhiyuan Wang; Zizhen Huang; Jiancong Huang; Gehua Zhang
Journal:  Cell Cycle       Date:  2018       Impact factor: 4.534

4.  Tetrandrine ameliorates dextran-sulfate-sodium-induced colitis in mice through inhibition of nuclear factor -kappaB activation.

Authors:  Dei Kui Zhang; Li Na Cheng; Xiao Li Huang; Wei Shi; Jun Ying Xiang; Hua Tian Gan
Journal:  Int J Colorectal Dis       Date:  2008-08-07       Impact factor: 2.571

5.  Tetrandrine triggers apoptosis and cell cycle arrest in human renal cell carcinoma cells.

Authors:  Tao Chen; Bing Ji; Yancui Chen
Journal:  J Nat Med       Date:  2013-04-06       Impact factor: 2.343

6.  Tetrandrine attenuated cerebral ischemia/reperfusion injury and induced differential proteomic changes in a MCAO mice model using 2-D DIGE.

Authors:  Lin Ruan; Huan-Sen Huang; Wen-Xiang Jin; Hai-Ming Chen; Xiong-Juan Li; Qing-Juan Gong
Journal:  Neurochem Res       Date:  2013-06-19       Impact factor: 3.996

7.  Tetrandrine and thapsigargin release arachidonic acid from cells in culture and stimulate prostacyclin production in rat liver cells, but may do so by different pathways.

Authors:  Lawrence Levine
Journal:  BMC Pharmacol       Date:  2005-06-24

8.  Tetrandrine suppresses lipopolysaccharide-induced microglial activation by inhibiting NF-κB and ERK signaling pathways in BV2 cells.

Authors:  Yalong Dang; Yongsheng Xu; Wentao Wu; Weiyi Li; Yanran Sun; Jing Yang; Yu Zhu; Chun Zhang
Journal:  PLoS One       Date:  2014-08-12       Impact factor: 3.240

9.  Tetrandrine combined with gemcitabine and Cisplatin for patients with advanced non-small cell lung cancer improve efficacy.

Authors:  Wenchao Liu; Ju Zhang; Cheng Ying; Qianrong Wang; Chen Yan; Yang Jingyue; Yu Zhaocai; Xue Yan; Shi Heng-Jun; Jiang Lin
Journal:  Int J Biomed Sci       Date:  2012-03

10.  Tetrandrine blocks autophagic flux and induces apoptosis via energetic impairment in cancer cells.

Authors:  W Qiu; M Su; F Xie; J Ai; Y Ren; J Zhang; R Guan; W He; Y Gong; Y Guo
Journal:  Cell Death Dis       Date:  2014-03-13       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.